levofloxacin has been researched along with tamsulosin in 7 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (tamsulosin) | Trials (tamsulosin) | Recent Studies (post-2010) (tamsulosin) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 1,460 | 468 | 693 |
| Protein | Taxonomy | levofloxacin (IC50) | tamsulosin (IC50) |
|---|---|---|---|
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0008 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0013 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0045 | |
| Alpha-1D adrenergic receptor | Mus musculus (house mouse) | 0.0018 | |
| Alpha-1B adrenergic receptor | Mus musculus (house mouse) | 0.0018 | |
| Alpha-1A adrenergic receptor | Mus musculus (house mouse) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| He, HX; He, Y; Qin, GD; Xiao, MZ; Yang, J; Zeng, Y; Zhou, YD | 1 |
| Chen, G; Chen, H; Chen, J; Li, T; Ouyang, L; Wang, X; Xiang, J; Zhang, S | 1 |
| Chen, JQ; Cheng, JL; Liao, XH; Wang, F; Wu, JT | 1 |
1 review(s) available for levofloxacin and tamsulosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for levofloxacin and tamsulosin
| Article | Year |
|---|---|
[Acupuncture combined with western medicine for CP/CPPS:a randomized controlled trial].
Topics: Acupuncture Points; Acupuncture Therapy; Chronic Disease; Chronic Pain; Combined Modality Therapy; Humans; Levofloxacin; Male; Pelvic Pain; Prostatitis; Sulfonamides; Tamsulosin; Treatment Outcome; Urological Agents | 2016 |
[Medication versus health education for patients with type Ⅲ prostatitis-like symptoms: A prospective randomized control study].
Topics: Adrenergic alpha-1 Receptor Antagonists; Chronic Disease; Humans; Levofloxacin; Male; Patient Education as Topic; Prospective Studies; Prostatitis; Quality of Life; Tamsulosin; United States; Urological Agents | 2019 |
4 other study(ies) available for levofloxacin and tamsulosin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Tamsulosin alters levofloxacin pharmacokinetics in prostates derived from rats with acute bacterial prostatitis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Anti-Bacterial Agents; Drug Interactions; Escherichia coli Infections; Kidney; Levofloxacin; Liver; Male; Ofloxacin; Prostate; Prostatitis; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin | 2013 |